| Family Circle Of Care | |
|
523 S Fannin Ave Tyler TX 75702-8204 | |
| (903) 535-9041 | |
| (903) 531-9490 |
| Full Name | Family Circle Of Care |
|---|---|
| Speciality | Clinic/Center |
| Location | 523 S Fannin Ave, Tyler, Texas |
| Authorized Official Name and Position | Kristen S Harris (CHIEF EXECUTIVE OFFICER) |
| Authorized Official Contact | 9035359041 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Family Circle Of Care 523 S Fannin Ave Tyler TX 75702-8204 Ph: (903) 535-9041 | Family Circle Of Care 523 S Fannin Ave Tyler TX 75702-8204 Ph: (903) 535-9041 |
| NPI Number | 1144575820 |
|---|---|
| Provider Enumeration Date | 07/18/2012 |
| Last Update Date | 04/08/2023 |
| Medicare PECOS PAC ID | 4587812888 |
|---|---|
| Medicare Enrollment ID | O20120911000666 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144575820 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | (* (Not Available)) | Secondary |
| 261QF0400X | Clinic/center - Federally Qualified Health Center (fqhc) | (Texas) | Primary |
| Provider Name | Mark Miles Barret |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1659341055 PECOS PAC ID: 5698662278 Enrollment ID: I20040228000348 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Marel A Hanks |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1306810593 PECOS PAC ID: 4385627306 Enrollment ID: I20040610001221 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Tamara L Jones |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1952439432 PECOS PAC ID: 3971579046 Enrollment ID: I20040909000602 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Toni L Richey |
|---|---|
| Provider Type | Practitioner - Certified Nurse Midwife (cnm) |
| Provider Identifiers | NPI Number: 1265560205 PECOS PAC ID: 1254390248 Enrollment ID: I20041006000169 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Robbin Langston |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1295936664 PECOS PAC ID: 0547228611 Enrollment ID: I20041221000986 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Jeffrey P Smith |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1760578835 PECOS PAC ID: 5294648366 Enrollment ID: I20050103000561 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Jacqueline Catney Dubois |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1043206147 PECOS PAC ID: 4587689146 Enrollment ID: I20051012000813 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Stephen P Rydzak |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1184656555 PECOS PAC ID: 0749193811 Enrollment ID: I20060908000408 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Stephen K Patrick |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1174542815 PECOS PAC ID: 6608970363 Enrollment ID: I20070406000104 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Cheryl Polkowski |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1194882241 PECOS PAC ID: 4385606698 Enrollment ID: I20081003000052 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Charla C Spencer |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1700851193 PECOS PAC ID: 5698732345 Enrollment ID: I20090422000613 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Wayne Karaki |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1871582924 PECOS PAC ID: 2264571710 Enrollment ID: I20091123000602 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Harold U Everett |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1225002850 PECOS PAC ID: 7214078633 Enrollment ID: I20100107000536 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Amanda Lynn Harris |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1336159128 PECOS PAC ID: 2264556927 Enrollment ID: I20100901000642 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Joseph L Petty |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1649461211 PECOS PAC ID: 1557486404 Enrollment ID: I20100915000587 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Jamekia T Bailey |
|---|---|
| Provider Type | Practitioner - Dentist |
| Provider Identifiers | NPI Number: 1831418680 PECOS PAC ID: 7012100746 Enrollment ID: I20101026000467 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Rachel Ann Everson |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1992936603 PECOS PAC ID: 0648469148 Enrollment ID: I20110114000412 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Nicholas Paul Luzietti |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1932119443 PECOS PAC ID: 6709065444 Enrollment ID: I20110126000862 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Mariellen A Speaker |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1457336265 PECOS PAC ID: 1658557897 Enrollment ID: I20110523000847 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Anne Whitney Cates |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1427348408 PECOS PAC ID: 9436327954 Enrollment ID: I20110727000283 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Judith D Sutherland |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1851611503 PECOS PAC ID: 6608046966 Enrollment ID: I20110824000878 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Katherine S Root |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1083932818 PECOS PAC ID: 2567606445 Enrollment ID: I20130916000064 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Margaret Vidal- Kutin |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1275533663 PECOS PAC ID: 8224272125 Enrollment ID: I20130916000313 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Eduardo Torres |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1255442653 PECOS PAC ID: 9335165075 Enrollment ID: I20131018001458 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Josephine Katherine Porter |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1346429677 PECOS PAC ID: 1254502511 Enrollment ID: I20140213000207 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Larry Shane Hilton |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1720153224 PECOS PAC ID: 4385643543 Enrollment ID: I20140707000636 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Lucianne Marin |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1821024654 PECOS PAC ID: 4385782325 Enrollment ID: I20140801001006 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Lamesa L Bell |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1548663784 PECOS PAC ID: 8426270042 Enrollment ID: I20141117000405 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | D'ann Glasco |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1134525561 PECOS PAC ID: 2365766102 Enrollment ID: I20150126002222 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Lell Alyne Pinkston |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1851797740 PECOS PAC ID: 8224353867 Enrollment ID: I20150203000208 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Amber N Cook |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1780944033 PECOS PAC ID: 2163646936 Enrollment ID: I20150602001692 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Edileola Makinde |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1811954852 PECOS PAC ID: 3476655721 Enrollment ID: I20160311001708 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Zareh H Khachikian |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1215084603 PECOS PAC ID: 3971698069 Enrollment ID: I20160504002547 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Stacy R Fogle |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1376093278 PECOS PAC ID: 6305126616 Enrollment ID: I20161202001064 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Juan P Garrido Morales |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1285073288 PECOS PAC ID: 5496054504 Enrollment ID: I20170131001527 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Khotwanaeya A Cohen |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1205198421 PECOS PAC ID: 0749593820 Enrollment ID: I20171017003312 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Lorena Santoro |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1114307790 PECOS PAC ID: 5991003485 Enrollment ID: I20180716001418 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Rabiah Zafar |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1235533027 PECOS PAC ID: 3072861830 Enrollment ID: I20180810000344 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Perla Cornelio Lopez |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1780169300 PECOS PAC ID: 8022352509 Enrollment ID: I20181211000832 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Sandra J Gooding |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1811541923 PECOS PAC ID: 5496083503 Enrollment ID: I20190828001314 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Kristina L Reyes |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1760037790 PECOS PAC ID: 7113257379 Enrollment ID: I20191001002419 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Marissa Ann Kuykendall |
|---|---|
| Provider Type | Practitioner - Certified Nurse Midwife (cnm) |
| Provider Identifiers | NPI Number: 1992356588 PECOS PAC ID: 5294168860 Enrollment ID: I20191212001399 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Kimberly L Mabry-paroline |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1104460328 PECOS PAC ID: 4880029537 Enrollment ID: I20200127002031 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Matthew Bryan Boehme |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1215460183 PECOS PAC ID: 4981026481 Enrollment ID: I20200629002115 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Kurtis G Kostan |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1134516172 PECOS PAC ID: 2860791886 Enrollment ID: I20200821000478 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | David Rice |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1902867260 PECOS PAC ID: 1456452796 Enrollment ID: I20201022004220 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Bhavani Suryadevara |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1710211578 PECOS PAC ID: 6002041001 Enrollment ID: I20210115001146 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Joshua Timothy Morgan |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1003304452 PECOS PAC ID: 4082978325 Enrollment ID: I20210512001730 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Angelica Maria Larios |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1912361288 PECOS PAC ID: 8426461104 Enrollment ID: I20210513001697 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Casie May Zarate |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1447925821 PECOS PAC ID: 8325446719 Enrollment ID: I20211015001369 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Donna Lachelle Jackson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1114531217 PECOS PAC ID: 1355732546 Enrollment ID: I20211223000112 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Roger Pearce |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1295706273 PECOS PAC ID: 2961569918 Enrollment ID: I20220502000791 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Shayna Burdeaux |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1386134633 PECOS PAC ID: 2860737814 Enrollment ID: I20220818003734 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Lakisha Nashun Bennings |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1609526771 PECOS PAC ID: 9537536743 Enrollment ID: I20221101000978 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Rachel Rene Baber |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1396469839 PECOS PAC ID: 5496122129 Enrollment ID: I20221109000461 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Valerie B Smith |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1073625737 PECOS PAC ID: 4688045073 Enrollment ID: I20230123001325 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | John D Kim |
|---|---|
| Provider Type | Practitioner - Dentist |
| Provider Identifiers | NPI Number: 1720531403 PECOS PAC ID: 7012380165 Enrollment ID: I20230310001117 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Deborah Garganera Ledesma |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1114625670 PECOS PAC ID: 7012381635 Enrollment ID: I20230322002746 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Lailane Pancho Asuncion |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1306545983 PECOS PAC ID: 6204200603 Enrollment ID: I20230327001956 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Amanda Michelle Walsh |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1003517244 PECOS PAC ID: 8628433745 Enrollment ID: I20230425001412 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Liliana Gelvez |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1205972957 PECOS PAC ID: 6204892318 Enrollment ID: I20230425003021 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Beverly S Hargrove |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1417113523 PECOS PAC ID: 9739078668 Enrollment ID: I20230524000036 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | John David Martino |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1285255877 PECOS PAC ID: 3678994746 Enrollment ID: I20230622000701 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Alyssa Weyer |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1598386039 PECOS PAC ID: 2163843285 Enrollment ID: I20230629002332 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Blake M Vincent |
|---|---|
| Provider Type | Practitioner - Dentist |
| Provider Identifiers | NPI Number: 1083747190 PECOS PAC ID: 2567815673 Enrollment ID: I20240125000168 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Gerard E Vallejo |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1285029538 PECOS PAC ID: 0840634754 Enrollment ID: I20240220000493 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
| Provider Name | Shweta Thambad |
|---|---|
| Provider Type | Practitioner - Dentist |
| Provider Identifiers | NPI Number: 1831864685 PECOS PAC ID: 6406292127 Enrollment ID: I20240315001751 |
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
News Archive
A content analysis of newspaper stories about organ and tissue donation, conducted by researchers at the University at Buffalo, found an almost 4:1 ratio of positive-to-negative articles on the subject.
Researchers at National Jewish Health have discovered that a naturally occurring lipid in the lung can prevent RSV infection and inhibit spread of the virus after an infection is established. RSV is the major cause of hospitalization for children in the first two years of life, and is increasingly recognized as a dangerous pathogen in adults with chronic lung diseases, the elderly, and immunocompromised individuals. Currently, there is no effective vaccine for the virus.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
Absolute Antibody Ltd. today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19.
› Verified 5 days ago
Pure Radiance Laser Retreat Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 6722 S Broadway Ave, Tyler, TX 75703 Phone: 903-561-0300 | |
Clifford D. Mullins, D.c., P.c. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 14653 Eastside Rd, Tyler, TX 75707 Phone: 903-566-4449 | |
Frank P Reuter Jr Md Pa Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 712 S Bois D Arc Ave, Tyler, TX 75701 Phone: 903-597-5579 Fax: 903-597-5722 | |
David W Ball Md Internal Medicine Pllc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 5407 New Copeland Rd Ste 200, Tyler, TX 75703 Phone: 903-330-2081 Fax: 903-630-9309 | |
Integrity Health Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 5605 Old Bullard Rd Ste B, Tyler, TX 75703 Phone: 903-630-5595 Fax: 903-630-5599 | |
Clinica Hispana Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 510 S Southwest Loop 323 Ste 140, Tyler, TX 75702 Phone: 903-530-0240 | |
Bwbl Group Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 6770 Old Jacksonville Hwy Ste 101, Tyler, TX 75703 Phone: 903-352-3250 Fax: 903-221-9183 |